Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-017217
Filing Date
2023-03-08
Accepted
2023-03-08 16:42:42
Documents
1
Period of Report
2023-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4034
  Complete submission text file 0001209191-23-017217.txt   5421
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
MCCOURT Thomas A (Reporting) CIK: 0001478448 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 23716683

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations